Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Dexrazoxane" patented technology

Dexrazoxane is used to reduce the risk and severity of heart damage caused by doxorubicin treatment and similar cancer chemotherapy medications.

Separation and detection method for related substances of dexrazoxane or preparation of dexrazoxane

The invention provides a separation and detection method for related substances of dexrazodone or preparations thereof, which adopts a high performance liquid chromatography-electrospray detector, can effectively separate dexrazodone and related substances thereof, has a good separation effect, does not have the problems of organic phase end absorption, background interference, poor baseline, large difference between impurities and principal component correction factors, and the like, and is suitable for large-scale industrial production. According to the method, the content of the related substances of the dexrazodone or the preparation thereof can be accurately measured, the purposes of effective separation, accurate quantification and cost saving are achieved, and the method is simple, convenient, high in specificity and capable of better controlling the quality of the dexrazodone and the preparation thereof.
Owner:YANGTZE RIVER PHARM GRP CO LTD

A prediction system for the anti-tumor effect of dexrazoxane in ESCC

ActiveCN115153576BAvoid the risk of failing to achieve cardioprotection with non-standard useSensorsMeasuring/recording heart/pulse rateChemo therapyIntracardiac Electrogram
The present invention relates to the field of anti-tumor technology. The present invention discloses an anti-tumor prediction system for dexrazoxane in ESCC, comprising a base, a bracket, a control device, a console, an electrocardiographic induction device, a detection probe, a magnet, a radio frequency generator, a data receiver, a shielding box, and a display screen, wherein the electrocardiographic induction device is connected to the upper part of the console, the magnetic field is used for a stable and non-changing magnetic field environment, the radio frequency generator is used for transmitting a pulse signal, the data receiver is used for transmitting the signal to the control device by wireless transmission, the prediction result is displayed on the display screen, the dexrazoxane concentration is changed by controlling the dosage of chemotherapy drugs, the heart damage is detected by electrocardiogram and magnetic resonance means, and an effective dexrazoxane use range can be predicted by combining historical data and experimental data to establish a dexrazoxane use prediction model, which avoids the risk of non-standard use of dexrazoxane failing to achieve heart protection to a certain extent.
Owner:NANYANG INST OF TECH

Application of MSR1 inhibitor in preparation of anti-tumor immunopotentiator

The invention discloses an application of an MSR1 inhibitor in preparation of an anti-tumor immunopotentiator. The MSR1 inhibitor is composed of doxylamine, trafenotide, dexrazoxane and clavulanic acid. The invention discloses application of an MSR1 inhibitor combined with an immune checkpoint inhibitor in preparation of a medicine for treating solid tumors. The MSR1 inhibitor disclosed by the invention is used as an anti-tumor immunopotentiator and is combined with an immune checkpoint inhibitor to treat solid tumors, so that the curative effect of tumor immunotherapy can be improved. The MSR1 inhibitor can induce tumor-related macrophages to be differentiated into anti-tumor subtypes, anti-tumor immunity is driven through phagocytosis and generation of cell factors, and a new method is provided for improving the curative effect of tumor immunotherapy.
Owner:JIANGSU PROVINCE HOSPITAL (THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY)